• FOXM1–Estrogen Receptor Interaction in Female Lung Adenocarc

  2026-06-02

  This study reveals a novel ceRNA network involving FOXM1 and estrogen receptor 1 in female lung adenocarcinoma, highlighting how FOXM1 expression shapes tumor progression and immunotherapy sensitivity. The findings provide a mechanistic basis for biomarker discovery and targeted research on estrogen receptor signaling in lung cancer.

• SREBP-1c Disrupts ULK1 Sulfhydration and Autophagy in NAFLD

  2026-06-02

  Nguyen et al. (2021) demonstrate that SREBP-1c impairs autophagic lipid degradation in high-fat-diet-fed mice by suppressing CSE/H2S-mediated sulfhydration of ULK1, thereby promoting hepatic steatosis. This mechanistic insight highlights the dual role of SREBP-1c in regulating both lipid synthesis and degradation, providing a refined understanding of non-alcoholic fatty liver disease (NAFLD) pathogenesis.

• Okadaic Acid (A4540): Practical Use as a PP1 Inhibitor

  2026-06-01

  Okadaic acid is a selective, marine-derived inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), enabling precise modulation of phosphorylation-dependent signaling in apoptosis and cancer research. It is best suited for protocols requiring targeted, nanomolar-range phosphatase inhibition, but should not be used where broad-spectrum phosphatase inhibition or unconventional solvents are necessary.

• CDC42-Driven Polarity Regulates Intestinal Stem Cell Fate vi

  2026-06-01

  The reference study demonstrates that CDC42-dependent apical-basal polarity orchestrates the transition from intestinal stem cells (ISCs) to transit amplifying (TA) cells through a Hippo-YAP-EGF-mTOR signaling cascade, independent of canonical Wnt pathways. These findings clarify the molecular framework underlying epithelial homeostasis, providing actionable targets for gastrointestinal research and stem cell modulation.

• DAPI Solution (1 mg/mL): Optimizing Nuclear Visualization Wo

  2026-05-31

  Unlock the full potential of 4',6-Diamidino-2-Phenylindole for apoptosis detection, viability assessment, and high-fidelity nuclear visualization. This guide bridges advanced PAD4 inhibitor research with actionable DAPI workflow enhancements, addressing protocol precision and troubleshooting for both fluorescence microscopy and flow cytometry.

• Fluconazole: Applied Workflows & Resistance Insights in Cand

  2026-05-30

  Fluconazole stands as the benchmark fungal cytochrome P450 enzyme 14α-demethylase inhibitor for dissecting antifungal susceptibility and drug resistance in Candida albicans. This article distills advanced protocols, troubleshooting strategies, and the latest mechanistic findings—empowering researchers to maximize reproducibility in antifungal and biofilm studies.

• SIRT3–SUMO Control of Treg Differentiation in Asthma via N-G

  2026-05-29

  This study reveals how SIRT3-SUMO regulates Treg cell differentiation and asthma progression by modulating N-glycosylation through the fatty acid oxidation pathway. The findings provide mechanistic insight into immune regulation in asthma and highlight new avenues for targeted intervention.

• ETS1 Modulates Mitophagy in BPD via SENP2/HSPA8/FUNDC1 Axis

  2026-05-29

  This article reviews a recent study identifying ETS1 as a key transcriptional regulator that protects against bronchopulmonary dysplasia (BPD) by suppressing mitochondrial damage-induced mitophagy through the SENP2/HSPA8/FUNDC1 pathway. These findings provide new mechanistic insights into chaperone-mediated autophagy in lung development and highlight potential molecular targets for BPD intervention.

• GSTA1 Drives Glutathione Loss in α-Amanitin Hepatotoxicity

  2026-05-28

  This study uncovers a paradoxical mechanism in which GSTA1, typically an antioxidant enzyme, exacerbates α-amanitin-induced liver injury by depleting glutathione and intensifying oxidative stress. The findings redefine GSTA1’s role in hepatic toxicity and suggest new therapeutic targets for acute liver injury research.

• Protease Inhibitor Cocktail: Safeguarding Protein Extraction

  2026-05-28

  The Protease Inhibitor Cocktail (100X in DMSO, EDTA plus) from APExBIO delivers broad-spectrum protein degradation prevention in even the most challenging extraction workflows. Discover how this solution elevates assay reproducibility and data integrity, with actionable protocol enhancements and troubleshooting strategies drawn from cutting-edge oncology research.

• Okadaic Acid (A4540): Protocols and QC for PP1/PP2A Inhibiti

  2026-05-27

  Okadaic acid is a potent inhibitor of protein phosphatase 1 (PP1) and 2A (PP2A), widely used to dissect phosphorylation-dependent signaling and apoptosis in cell biology and cancer research. It provides robust, nanomolar-range inhibition, but its strong activity and solvent formulation demand precise handling and protocol optimization. Okadaic acid should be avoided in contexts where non-specific phosphatase inhibition or solvent interference could compromise results.

• Phosphatase Inhibitor Cocktail 3 (100X in DMSO): Protocol Gu

  2026-05-27

  Phosphatase Inhibitor Cocktail 3 (100X in DMSO) addresses the challenge of preserving protein phosphorylation during extraction, preventing artifactual dephosphorylation by endogenous phosphatases. This product is intended for workflows requiring accurate analysis of phosphorylation states, such as Western blotting and kinase assays, but is not suitable for workflows incompatible with DMSO or where phosphatase inhibition is not required.

• ALDH2 Activation Enhances Cardiomyocyte Proliferation in Hea

  2026-05-26

  This study demonstrates that ALDH2 activation, achieved pharmacologically, significantly extends the window of cardiomyocyte proliferation and delays the onset of heart failure following pressure overload in mice. These findings highlight ALDH2 as a promising target for cardiac regeneration and provide a mechanistic basis for new therapeutic strategies in heart failure research.

• CD28-ARS2 Axis Drives PKM Splicing for CD8+ T Cell Flexibili

  2026-05-26

  This study reveals that the CD28-ARS2 signaling axis promotes alternative splicing of pyruvate kinase (PKM) in CD8+ T cells, enabling metabolic flexibility essential for potent antitumor immunity. By mapping the distinct mechanisms governing PKM isoform expression, this research advances understanding of T cell immunometabolism and provides a new framework for modulating T cell function in cancer research.

• Honokiol: Applied Workflows for In Vitro NF-κB Pathway Inhib

  2026-05-25

  Honokiol is a versatile small molecule for dissecting NF-κB-driven inflammation and tumor microenvironment dynamics. This guide translates cutting-edge in vitro drug response methodologies into actionable protocols, troubleshooting, and comparative advantages—empowering translational researchers to optimize Honokiol’s impact in cancer and oxidative stress research.

16293 records 1/1087 page Next 12345 下5页 Last page